The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
about
Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapyHyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imagingModulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motilityForced expression of S100A10 reduces sensitivity to oxaliplatin in colorectal cancer cellsActivation of NF-κB signalling by fusicoccin-induced dimerization.Pigment epithelium-derived factor protects retinal ganglion cells.In vitro anticancer property of a novel thalidomide analogue through inhibition of NF-kappaB activation in HL-60 cellsEpigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.TAp63 is a transcriptional target of NF-kappaB.TransFind--predicting transcriptional regulators for gene sets.Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-κB in vitro and in vivo.TBX3 over-expression causes mammary gland hyperplasia and increases mammary stem-like cells in an inducible transgenic mouse model.Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo.The role of n-3 polyunsaturated fatty acids in the prevention and treatment of breast cancerThe role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomasHeat shock protein 90-mediated inactivation of nuclear factor-κB switches autophagy to apoptosis through becn1 transcriptional inhibition in selenite-induced NB4 cells.Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2Association between hTERT polymorphisms and the risk of breast cancer in a sample of Southeast Iranian population.MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway.Inhibition of cathepsin L sensitizes human glioma cells to ionizing radiation in vitro through NF-κB signaling pathway.Celecoxib sensitizes Staphylococcus aureus to antibiotics in macrophages by modulating SIRT1.Association between Programmed Cell Death 6 Interacting Protein Insertion/Deletion Polymorphism and the Risk of Breast Cancer in a Sample of Iranian Population.APOBEC3 Deletion is Associated with Breast Cancer Risk in a Sample of Southeast Iranian Population.Regulation of IKKε Expression by Akt2 Isoform.Eye drop delivery of pigment epithelium-derived factor-34 promotes retinal ganglion cell neuroprotection and axon regeneration.TBX3 promotes human embryonic stem cell proliferation and neuroepithelial differentiation in a differentiation stage-dependent mannerSoybean glyceollins mitigate inducible nitric oxide synthase and cyclooxygenase-2 expression levels via suppression of the NF-κB signaling pathway in RAW 264.7 cellsPigment epithelium-derived factor is retinal ganglion cell neuroprotective and axogenic after optic nerve crush injury.Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancerSize-dependent regulation of Snail2 by hyaluronan: its role in cellular invasion.FEN1 -69G>A and +4150G>T polymorphisms and breast cancer riskComprehensive evaluation of a novel nuclear factor-kappaB inhibitor, quinoclamine, by transcriptomic analysisIKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cells.β1-Integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer.The design and development of imidazothiazole-chalcone derivatives as potential anticancer drugs.Concomitant resistance and early-breast cancer: should we change treatment strategies?Seed-based systematic discovery of specific transcription factor target genes.NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699.Overexpression of receptor for advanced glycation end products (RAGE) in ovarian cancer.
P2860
Q22299231-ED7D7862-D749-4678-A55E-D26EB1550E12Q24319922-15597152-A5EC-460B-A9D9-D6CF474088F1Q28481421-817C17B1-2C24-4A80-93FF-F48AF7E59661Q28594979-83284B47-2D46-486F-8B21-3A9E32562661Q28659746-52889F68-2AA4-4866-A4E3-A9FAB9143527Q30533996-20C8F1E5-5757-4CC5-B7D3-65ACE3A149BFQ33270756-7C2C7FDC-7554-4972-B3CA-DC93D8B15213Q33552178-CB527155-E8EF-498E-B309-2D2D481EB9AFQ33782392-B6BB0186-6757-4BB6-B97A-117069690A0AQ33866001-54498422-D7F0-4F83-AC85-1E008395EAC5Q33957480-08129CED-6C15-4785-8853-65E1A78258C3Q34000612-A2FD2925-4A48-464F-94E0-502050D9C7A9Q34062681-ADAEAF33-7323-4686-BE44-57303F348341Q34435015-468CB980-67F4-4B19-88AF-952DEE16BF69Q34578129-A2D25733-0840-4CBC-A8BB-326F6B7CD8E8Q34694988-5A4531E6-769B-4FDB-89E0-B2A2DA805CA4Q34803115-CC992745-67C9-45A9-AE2A-820E95C84446Q34891145-EBDB204F-88FE-48DE-9CBA-6EDF9E16B00CQ34967865-A20CD9F7-D362-40F5-8785-7A03EF13A455Q35051948-C5E9CB11-9BE8-490A-A331-4D67DBBF94CEQ35148208-03D1A1E4-FC3A-418A-8258-BC3199F45AC1Q35192174-F667AC16-DC9D-4B2A-B7D6-09234D01D8BDQ35612572-841884E6-1629-47B6-816D-EF3ECDD5854FQ35843760-7B679E8E-29BC-4E27-A232-F1F311B299EAQ36047103-C0CD6B1A-2ABC-46BC-8E31-B9A053696ADAQ36159673-022AF5A3-7E45-4328-AE75-27033EA992F3Q36454601-9607AFF6-AAEE-4FA1-A48E-30D03B093456Q36613675-5B893EF4-2203-4435-89E8-075015CBF974Q36779341-E064B358-508E-48C3-861A-28CFB880CE15Q37074177-13943C41-568B-4487-9CDE-CE8293A63A98Q37248258-2CF755BE-9038-479F-BAC0-F4DDB78FA744Q37288317-CE8F7137-6940-4E02-A06A-10DC4B834355Q37290391-9675F441-BE42-430C-AD3E-729CEEF18B99Q37688677-44464B7D-A89B-4DC6-A69C-34ED06598CE8Q37689916-2E8CA351-0A6D-459B-91A5-6A9C5711B2D7Q38073888-E1CB654D-315F-417B-8E2B-79403511D8B8Q38171964-844241AC-C112-441B-8932-7B52CC6D5236Q38290906-CBB9306D-A50A-4CD8-AB6D-B8934449E99AQ38677373-F679BB8A-7709-4AD2-AF83-E9B3983CB29AQ38732977-4DD5F33C-7AE6-4F33-8C50-F0106B3C138B
P2860
The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
@ast
The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
@en
type
label
The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
@ast
The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
@en
prefLabel
The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
@ast
The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
@en
P1476
The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
@en
P2093
James T Wu
John G Kral
P304
P356
10.1016/J.JSS.2004.06.006
P577
2005-01-01T00:00:00Z